Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmen Quan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Radiation Oncology|March 23, 2016
Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell CarcinomaKimmen Quan, Karen M Xu, Yongqian Zhang, et al.
Journal of Medical Imaging and Radiation Oncology|February 16, 2022
Salvage radiotherapy following HiFU: An institutional series and literature reviewAruz Mesci, Mohammad Gouran-Savadkoohi, Derek Ribeiro, et al.
Acta Oncologica (Stockholm, Sweden)|April 18, 2022
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic diseaseSherif Ramadan, Kimmen Quan, Kara Schnarr, et al.
Advances in Radiation Oncology|April 24, 2019
Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive MarginsMark E Bernard, Philip A Sutera, Nicholas A Iarrobino, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Surveillance After Extremity Tumor Surgery (SAFETY) Pilot International Multi-Center Randomized Controlled TrialHadia Farrukh, Patricia Schneider, Tess Hudson, et al.
Urology|March 9, 2025
A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER)Raees Cassim, Rahul Bansal, Braden Millan, et al.
Frontiers in Oncology|November 30, 2017
One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective ReviewPhilip Anthony Sutera, Mark E Bernard, Beant S Gill, et al.
Practical Radiation Oncology|January 3, 2018
Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinomaKimmen Quan, Philip Sutera, Karen Xu, et al.
Frontiers in Oncology|October 27, 2015
Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated RadiosurgeryKimmen Quan, Karen M Xu, Ron Lalonde, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 17, 2024
Patterns of failure with <sup>18</sup>F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting A regional cohort analysisSamantha Sigurdson, Khalid Al Salman, Aruz Mesci, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Radiation Oncology|March 23, 2016
Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell CarcinomaKimmen Quan, Karen M Xu, Yongqian Zhang, et al.
Journal of Medical Imaging and Radiation Oncology|February 16, 2022
Salvage radiotherapy following HiFU: An institutional series and literature reviewAruz Mesci, Mohammad Gouran-Savadkoohi, Derek Ribeiro, et al.
Acta Oncologica (Stockholm, Sweden)|April 18, 2022
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic diseaseSherif Ramadan, Kimmen Quan, Kara Schnarr, et al.
Advances in Radiation Oncology|April 24, 2019
Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive MarginsMark E Bernard, Philip A Sutera, Nicholas A Iarrobino, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Surveillance After Extremity Tumor Surgery (SAFETY) Pilot International Multi-Center Randomized Controlled TrialHadia Farrukh, Patricia Schneider, Tess Hudson, et al.
Urology|March 9, 2025
A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER)Raees Cassim, Rahul Bansal, Braden Millan, et al.
Frontiers in Oncology|November 30, 2017
One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective ReviewPhilip Anthony Sutera, Mark E Bernard, Beant S Gill, et al.
Practical Radiation Oncology|January 3, 2018
Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinomaKimmen Quan, Philip Sutera, Karen Xu, et al.
Frontiers in Oncology|October 27, 2015
Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated RadiosurgeryKimmen Quan, Karen M Xu, Ron Lalonde, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 17, 2024
Patterns of failure with <sup>18</sup>F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting A regional cohort analysisSamantha Sigurdson, Khalid Al Salman, Aruz Mesci, et al.
Pageof 3